Rick Niu, CEO of the US group corporation Starr Strategic Partners and Senior Managing Director of Starr Companies, visited Sanpower Group on 25 March. Yuan Yafei, Chairman of Sanpower Group, received the guest, accompanied by Yue Lei, Senior Vice President of Sanpower Group, and Jiang Zhenglin, General Manager of Shanghai Tongren Insurance Brokerage.

Yue Lei led Rick Niu to visit the corporate culture showroom Sanpower Home, the Brookstone concept store and the Senior-Care Service Command Centre. Then he introduced the development history and the five strategic sectors of Sanpower Group and gave a detailed explanation of the "three carriages" promoting Sanpower's future development, that is, the three industries of "Broad Consumption, Broad Health and Broad Finance".

In June 2015, Shanghai Tongren Insurance Brokerage controlled by Sanpower Group signed a strategic cooperation agreement with Starr Property & Casualty Insurance (China) Co., Ltd., a Chinese member company of Starr Companies. Their all-round cooperation laid the foundation for this visit.

As introduced by Rick Niu, Starr Companies is a global insurance and finance services provider as well as a multinational investment agency whose business has been expanded across the world. Starr is very optimistic about the future of the Chinese market. Actually, Starr Strategic Partners was specially established to provide cross-border capital operation and investment services for Asian enterprises and individuals and satisfy their needs for investment, insurance and strategies when they are expanding business in the US. Considering the industry layout of Sanpower Group, he introduced to Yuan Yafei multiple investment opportunities in the US finance and insurance as well as health care fields. He also invited Yuan Yafei to make an on-the-spot investigation.

As noted by Chairman Yuan Yafei, Starr Companies is the “pioneer” of the insurance industry and boasts a long history and rich global resources. Meanwhile, the US enjoys world-leading medical technology. It can provide a development direction for Sanpower’s precision medicine. Both sides expressed their wish to maintain communication with each other, seek potential investment opportunities and conduct worldwide cooperation in the fields of health care and finance.